Otto C. Boerman

27.9k total citations · 1 hit paper
494 papers, 22.0k citations indexed

About

Otto C. Boerman is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Otto C. Boerman has authored 494 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 262 papers in Radiology, Nuclear Medicine and Imaging, 119 papers in Pulmonary and Respiratory Medicine and 114 papers in Molecular Biology. Recurrent topics in Otto C. Boerman's work include Radiopharmaceutical Chemistry and Applications (201 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Medical Imaging Techniques and Applications (68 papers). Otto C. Boerman is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (201 papers), Monoclonal and Polyclonal Antibodies Research (94 papers) and Medical Imaging Techniques and Applications (68 papers). Otto C. Boerman collaborates with scholars based in Netherlands, United States and Germany. Otto C. Boerman's co-authors include Wim J.G. Oyen, Frans H.M. Corstens, Peter Laverman, Martin Gotthardt, Egbert Oosterwijk, Carl G. Figdor, David M. Goldenberg, Gerben M. Franssen, Gosse J. Adema and Gert Storm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Otto C. Boerman

491 papers receiving 21.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

2005 666 citations I. Jolanda M. de Vries, W. Joost Lesterhuis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Otto C. Boerman Netherlands	75	8.8k	6.2k	5.7k	3.6k	3.1k	494	22.0k
Wim J.G. Oyen Netherlands	87	12.9k 1.5×	5.8k 0.9×	7.2k 1.3×	6.2k 1.7×	2.8k 0.9×	689	30.8k
Kevin J. Harrington United Kingdom	85	3.0k 0.3×	9.2k 1.5×	13.5k 2.4×	6.0k 1.7×	5.0k 1.6×	768	31.6k
Wadih Arap United States	66	3.5k 0.4×	10.4k 1.7×	4.3k 0.8×	1.4k 0.4×	1.8k 0.6×	234	18.3k
Renata Pasqualini United States	69	4.4k 0.5×	12.0k 1.9×	4.4k 0.8×	1.0k 0.3×	2.1k 0.7×	243	20.5k
John V. Frangioni United States	72	4.0k 0.5×	7.6k 1.2×	3.0k 0.5×	4.6k 1.3×	1.2k 0.4×	236	28.3k
Henry Brem United States	75	2.1k 0.2×	5.1k 0.8×	3.4k 0.6×	3.1k 0.9×	1.4k 0.4×	373	21.4k
Clemens W.G.M. Löwik Netherlands	78	2.1k 0.2×	9.2k 1.5×	6.5k 1.1×	2.4k 0.7×	1.7k 0.5×	296	20.3k
Mark H. Ginsberg United States	108	3.9k 0.4×	16.5k 2.6×	3.4k 0.6×	3.1k 0.9×	6.2k 2.0×	359	41.6k
Elena Aïkawa United States	78	2.4k 0.3×	6.5k 1.0×	1.6k 0.3×	4.0k 1.1×	5.2k 1.6×	261	22.1k
Hisataka Kobayashi United States	75	3.4k 0.4×	6.9k 1.1×	3.6k 0.6×	6.2k 1.7×	2.8k 0.9×	444	25.3k

Countries citing papers authored by Otto C. Boerman

Since Specialization

Citations

This map shows the geographic impact of Otto C. Boerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto C. Boerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto C. Boerman more than expected).

Fields of papers citing papers by Otto C. Boerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto C. Boerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto C. Boerman. The network helps show where Otto C. Boerman may publish in the future.

Co-authorship network of co-authors of Otto C. Boerman

This figure shows the co-authorship network connecting the top 25 collaborators of Otto C. Boerman. A scholar is included among the top collaborators of Otto C. Boerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto C. Boerman. Otto C. Boerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bos, Desirée L., et al.. (2019). Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models. EJNMMI Research. 9(1). 108–108. 8 indexed citations

Heskamp, Sandra, Janneke D.M. Molkenboer‐Kuenen, Soley Thordardottir, et al.. (2018). PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer. Cancer Immunology Research. 7(1). 150–161. 30 indexed citations

Hekman, Marlène C.H., Otto C. Boerman, Desirée L. Bos, et al.. (2016). Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study. Clinical Cancer Research. 22(18). 4634–4642. 34 indexed citations

Swarts, Herman G.P., Otto C. Boerman, Jan J. Koenderink, et al.. (2016). Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways. Molecular Cancer Therapeutics. 16(1). 169–181. 20 indexed citations

Franssen, Gerben M., et al.. (2015). A Fully Automated Procedure for the GMP-Synthesis of 68Ga-NODAGA-Exendin-4 Using a Cationic Purification Method. European Journal of Nuclear Medicine and Molecular Imaging. 42. 2 indexed citations

Laverman, Peter, Lieke Joosten, Maggie Cooper, et al.. (2014). PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with ⁶⁴Cu, ⁶⁸Ga, and ¹¹¹In. Molecular Pharmaceutics. 11(11). 3930–3937. 62 indexed citations

Brom, Maarten, Lieke Joosten, Cathelijne Frielink, et al.. (2014). Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin. Diabetologia. 57(5). 950–959. 109 indexed citations

Heskamp, Sandra, Hanneke W.M. van Laarhoven, Wim J.G. Oyen, W. Van der Graaf, & Otto C. Boerman. (2013). Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring. Current Molecular Medicine. 13(10). 1506–1522. 7 indexed citations

Tel, Jurjen, Erik H.J.G. Aarntzen, Tetsuro Baba, et al.. (2013). Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients. Cancer Research. 73(3). 1063–1075. 289 indexed citations

10.

Lesterhuis, W. Joost, I. Jolanda M. de Vries, Gerty Schreibelt, et al.. (2011). Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients. Clinical Cancer Research. 17(17). 5725–5735. 138 indexed citations

11.

Fleuren, Emmy D.G., Yvonne M.H. Versleijen‐Jonkers, Addy C.M. van de Luijtgaarden, et al.. (2011). Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507. Clinical Cancer Research. 17(24). 7693–7703. 37 indexed citations

12.

Simon, Anna, Bart Jan Kullberg, Brian Tripet, et al.. (2008). Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity. Antimicrobial Agents and Chemotherapy. 52(4). 1407–1412. 40 indexed citations

13.

Sutmuller, Roger P.M., Stefan Nierkens, Erik Bennink, et al.. (2006). Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. British Journal of Cancer. 95(7). 896–905. 228 indexed citations

14.

Boerman, Otto C., et al.. (2006). Targeting of Biliary Cancer with Radiolabeled Chimeric Monoclonal Antibody CG250. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 263–268. 6 indexed citations

15.

Rennen, Huub J J M, Chantal P. Bleeker‐Rovers, Cathelijne Frielink, et al.. (2004). 99m Tc-Labeled Interleukin-8 for Scintigraphic Detection of Pulmonary Infections. CHEST Journal. 126(6). 1954–1961. 15 indexed citations

16.

Janssen, Marcel, Cathelijne Frielink, Ingrid Dijkgraaf, et al.. (2004). Improved Tumor Targeting of Radiolabeled RGD Peptides Using Rapid Dose Fractionation. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 399–404. 38 indexed citations

17.

Boerman, Otto C., et al.. (2001). Liposomes as sustained release system for human interferon-γ: biopharmaceutical aspects. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1530(2-3). 134–145. 60 indexed citations

18.

Boerman, Otto C., E.T.M. Dams, Wim J.G. Oyen, Frans H.M. Corstens, & G. Storm. (2001). Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Inflammation Research. 50(2). 55–64. 36 indexed citations

19.

Boerman, Otto C., Wim J.G. Oyen, & Frans H.M. Corstens. (2000). Pretargeted Radioimmunotherapy of Non-Hodgkin's Lymphoma: Best of Both Worlds?. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 1–5. 1 indexed citations

20.

Oyen, Wim J.G., Otto C. Boerman, G. Storm, et al.. (1996). Labelled StealthR liposomes in experimental infection. Nuclear Medicine Communications. 17(9). 742–748. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact